Climate Change Data

Kopran Limited

Climate Impact & Sustainability Data (2022-23, 2023-24)

Reporting Period: 2022-23

Environmental Metrics

Total Carbon Emissions:28847 tCO2e/year (Scope 1 & 2)
Scope 1 Emissions:16744 tCO2e/year
Scope 2 Emissions:12103 tCO2e/year
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:172039 (A+B+C)/year
Water Consumption:127117 kilolitres/year
Waste Generated:84.04 metric tonnes/year
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Product quality and safety
  • Innovation
  • Sustainable supply chain
  • Regulatory compliance
  • Environmental performance and climate change
  • Investment in R&D
  • Employee well-being
  • Community engagement
  • Transparency
  • Ethics
  • Diverse board
  • Compliance

Environmental Achievements

  • Implemented an Effluent Treatment Plant (ETP) to manage waste responsibly.
  • Engaging in carbon offsetting efforts by initiating tree plantations.
  • Adopting upgraded, energy-efficient resources for its operations.
  • Installed 25 solar panel street light fixtures.
  • Developing a green belt on leased land.

Social Achievements

  • Ensuring equal opportunities for all individuals, regardless of their caste, creed, gender, race, religion, disability, or sexual orientation.
  • Providing regular training to enhance employees’ awareness and skills in handling potential hazards.
  • Established an Internal Committee for addressing complaints related to sexual harassment.

Governance Achievements

  • Adopted a ‘Code of Conduct’ Policy for its Directors, KMPs and Senior Management to ensure the highest standards of Corporate Governance.
  • Has a whistle-blower policy.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Product quality and safety risks impacting patient health and regulatory compliance.
  • Supply chain sustainability challenges.
  • Regulatory compliance risks leading to legal action, fines, and penalties.
  • Environmental performance and climate change risks, including GHG emissions and climate change impacts.
  • Potential for anti-competitive conduct.
Mitigation Strategies
  • Implemented a robust Quality Management System and adheres to healthy manufacturing practices.
  • Developed a strong evaluation system to analyse the implications of unforeseen disruptions on the supply chain.
  • Actively engaging with regulatory agencies.
  • Initiating proactive measures to address physical and transitional risks associated with climate change, such as decarbonising operations, implementing GHG emission reduction strategies and conducting climate risk assessments.
  • No instances of anti-competitive conduct reported.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Vendor management and transport validation procedures; annual vendor rating system.

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: US FDA, EU GMP, WHO GMP, COFEPRIS, KFDA, ANVISA

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2023-24

Environmental Metrics

Total Carbon Emissions:14,222 + 8460 = 22682 Metric tonnes of CO2 equivalent
Scope 1 Emissions:14,222 Metric tonnes of CO2 equivalent
Scope 2 Emissions:8460 Metric tonnes of CO2 equivalent
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:134,328.00 (2024) and 172,039.00 (2023)
Water Consumption:134,528 (2024) and 127,117 (2023) kilolitres
Waste Generated:44.33 (2024) and 84.04 (2023) metric tonnes
Carbon Intensity:0.48 (2024) and 0.52 (2023) Metric tonnes of CO2 equivalent/Turnover in Crore

ESG Focus Areas

  • Product quality and safety
  • Innovation
  • Sustainable Supply chain
  • Regulatory compliance
  • Environmental performance and climate change
  • Investment in R&D

Environmental Achievements

  • Implemented eco-friendly atomisation for enhanced resource efficiency and manufacturing sustainability, resulting in reduced energy consumption and waste generation.
  • Installed 25 solar panel street light fixtures.
  • Undertook tree plantations and developing a green belt.

Social Achievements

  • Ensured accessibility of workplaces for differently abled employees and workers.
  • Implemented robust mechanisms to receive and redress grievances of the community.
  • Undertook CSR projects in designated aspirational districts.

Governance Achievements

  • Strengthened governance practices to ensure transparency and regulatory compliance.
  • Implemented a whistle-blower mechanism to report misconduct.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Product quality and safety risks impacting patient health and regulatory compliance.
  • Supply chain sustainability challenges.
  • Regulatory compliance risks.
  • Environmental performance and climate change risks.
  • Potential conflicts of interest.
Mitigation Strategies
  • Implemented a robust Quality Management System and adheres to healthy manufacturing practices.
  • Developed a strong evaluation system to analyze the implications of unforeseen disruptions on the supply chain.
  • Continuously emphasizing and establishing its presence in larger markets and enhancing regulatory capabilities.
  • Initiating proactive measures to address physical and transitional risks associated with climate change.
  • Established policies to mitigate and manage conflicts of interest among board members.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Vendor management and transport validation procedures, annual vendor rating system

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: GMP Certification by FDA, Government of Maharashtra. WHO GMP Certification by CDSCO, Government of India.

Third-party Assurance: Not Applicable

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed